Claire Worrall
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
Journal: Oncogene
Published: September 09, 2024
IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.
Journal: Oncotarget
Published: March 07, 2018
Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation.
Journal: Oncotarget
Published: March 31, 2017
Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.
Journal: Oncogene
Published: January 16, 2017
Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling.
Journal: Progress in molecular biology and translational science
Published: July 06, 2016
The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?
Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published: July 14, 2014
Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications.
Journal: Pediatric endocrinology reviews : PER
Published: August 21, 2013
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.
Journal: Cellular and molecular life sciences : CMLS
Published: May 11, 2013
β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 29, 2012
Last Updated: 09/26/2026